Evidence map›Paper›PMID 38926805›Full record

ArticleActa neuropathologica communications2024

Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-altered.

Arnault Tauziède-Espariat, David Castel, Yassine Ajlil, Lucie Auffret, Romain Appay, Cassandra Mariet, Lauren Hasty, Alice Métais, Fabrice Chrétien, Jacques Grill and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta neuropathologica communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Neuro-oncology advances
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Arnault Tauziède-EspariatGHU Paris Psychiatrie Neurosciences, Department of Neuropathology, Sainte-Anne Hospital, 1, rue Cabanis, Paris, 75014, France. a.tauziede-espariat@ghu-paris.fr.
David CastelU981, Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris- Saclay, Villejuif, 94805, France.
Yassine AjlilU981, Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris- Saclay, Villejuif, 94805, France.
Lucie AuffretU981, Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris- Saclay, Villejuif, 94805, France.
Romain AppayDepartment of Pathology, APHM La Timone, Marseille, France.
Cassandra MarietGHU Paris Psychiatrie Neurosciences, Department of Neuropathology, Sainte-Anne Hospital, 1, rue Cabanis, Paris, 75014, France.
Lauren HastyGHU Paris Psychiatrie Neurosciences, Department of Neuropathology, Sainte-Anne Hospital, 1, rue Cabanis, Paris, 75014, France.
Alice MétaisGHU Paris Psychiatrie Neurosciences, Department of Neuropathology, Sainte-Anne Hospital, 1, rue Cabanis, Paris, 75014, France.
Fabrice ChrétienGHU Paris Psychiatrie Neurosciences, Department of Neuropathology, Sainte-Anne Hospital, 1, rue Cabanis, Paris, 75014, France.
Jacques GrillParis University France, Paris, 75006, France.
Pascale VarletGHU Paris Psychiatrie Neurosciences, Department of Neuropathology, Sainte-Anne Hospital, 1, rue Cabanis, Paris, 75014, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Brain NeoplasmsGliomaX-linked Nuclear ProteinAtaxia Telangiectasia Mutated ProteinsHistonesHumansMaleAtaxia Telangiectasia Mutated ProteinsATRX protein, humanHistonesX-linked Nuclear Protein

Identifiers

PMID38926805
PMCPMC11209953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.